METHODS: This quasi-experimental study assessed the impact of an anemia DMT on laboratory test ordering by primary care providers for anemic patients. This study included adult patients (≥18 years) with anemia (hemoglobin <12.0 g/dL for nonpregnant women, hemoglobin <13.0 g/dL for men) presenting to a family medicine clinic. Cases reviewed by the DMT (n = 100) were compared with a control group (n = 95).
RESULTS: The DMT recommended additional testing for 76 patients. Significantly more patients in the DMT group underwent follow-up tests compared with controls (59% vs 34%; P < .001). Moreover, the DMT group underwent a higher mean number of tests per patient (1.70 ± 2.2 vs 0.95 ± 1.9; P = .01).
CONCLUSIONS: Implementation of an anemia DMT influenced follow-up testing patterns in anemic patients, potentially enhancing diagnostic thoroughness and patient care.
方法:这项准实验研究评估了贫血DMT对初级保健提供者为贫血患者订购实验室检查的影响。这项研究包括成人患者(≥18岁)贫血(血红蛋白<12.0g/dL的非妊娠妇女,男性的血红蛋白<13.0g/dL)提交给家庭医学诊所。将DMT审查的病例(n=100)与对照组(n=95)进行比较。
结果:DMT建议对76例患者进行额外检测。与对照组相比,DMT组接受随访测试的患者明显更多(59%vs34%;P<.001)。此外,DMT组每位患者接受的平均检查次数较高(1.70±2.2vs0.95±1.9;P=.01).
结论:实施贫血DMT影响贫血患者的随访检测模式,有可能增强诊断彻底性和患者护理。